The findings reach people, from one lab or study; independent labs found the same change in cells and mice. 57 independent labs in 18 countries; 2 trials, 1 with no results posted.
“insulin-like growth factor-1 (IGF-1) mediated 4.2% of the total effect through enhanced growth signaling (P = 0.0265)”
Cells and mice: replicated by independent labs. Humans: a single group. Worms or flies: nothing yet.
C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.
Labs are independent when their papers share no last author and no institution.
Against: findings that point the other way from most findings on the same outcome.
No results posted: trials that ended over a year ago with no results on ClinicalTrials.gov and no paper reporting them.
Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.
Includes the processes named after it and trials of drugs aimed at it.
57 independent labs in 18 countries
6 findings against
2 trials, 1 with no results posted
Funders: National Institute on Aging and others
5 of 117 findings with company ties
2 of 2 trials sponsored by developers of drugs aimed at it
Human trial56
Humans82
Animals280
Cells33
In silico12
Interventions
23
Caloric restriction
↓downin cattle1↑upin mice1↓downin rats1
3 studies
Caloric restriction decreases IGF1 in cattle (40% less (P < 0.05)).
“Expression of IGF-1, a PGC1α-4 target gene, was 40% less (P < 0.05) in CR than CON.”
“In addition, we found that HES ameliorated the sarcopenia by regulating AKT/mammalian target of rapamycin/forkhead box 3a signaling through an increase in insulin-like growth factor (IGF)-1 expression in the old mice.”
↓downin human cells2↓downin mice2→is required forin human cells1↓downin humans1+3
8 studies
IGF1 is required for cellular senescence in mouse cells (required for benzo[a]pyrene-triggered microglial senescence).
“insulin-like growth factor 1 (IGF-1), as a direct downstream effector regulated by TREM2, is functionally required for B[a]P-triggered microglial senescence.”
Cellsrequired for benzo[a]pyrene-triggered microglial senescencemicroglia
IGF1 is required for cellular senescence in human cells.
“Rescue experiments demonstrated that IGF-1 silencing abolished the inhibitory impact of FOXP1 overexpression on ox-LDL-induced cellular senescence and NLRP3 activation in HAECs.”
CellsRequired for FOXP1-overexpression-mediated suppression in ox-LDL-stimulated cells, shown by IGF-1 silencinghuman aortic endothelial cells
IGF1 is linked with a higher risk of osteoporosis in humans (meta-analysis of 4 studies, judged by TSA) (OR: 1.24 (95% CI: 1.05-1.47)).
“integration of our case-control study and 3 published studies, rs35767 [OR: 1.24 (95% CI: 1.05-1.47)] showed a conclusively risk association with OP in postmenopausal females”
Humansmeta-analysis of 4 studies, judged by TSAfemalesn = 2,267
IGF1 is linked with a lower risk of low hand grip strength in humans (genetically predicted levels (Mendelian randomization)) (OR 0.936 (95% CI 0.892-0.983)).
“elevated levels of IGF-1 reduced the risk of low hand grip strength (OR = 0.936, 95% CI=0.892-0.983, P = 0.008)”
Exposed mice developed dose-dependent movement and thinking problems, alongside signs of senescence, a state in which cells stop dividing, in brain immune cells.Exposed mice developed dose-dependent movement and thinking problems, alongside signs of senescence, a state in which cells stop dividing, in brain immune cells.